These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9534297

  • 1. [The role of 4G/5G polymorphism in the regulation of plasma levels of PAI-1: a model of interaction between genetic and environmental factors].
    Burzotta F, Di Castelnuovo A, Amore C, D'Orazio A, Donati MB, Iacoviello L.
    Cardiologia; 1998 Jan; 43(1):83-8. PubMed ID: 9534297
    [Abstract] [Full Text] [Related]

  • 2. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 3. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A.
    Ann Acad Med Stetin; 2005 Dec; 51(1):95-105. PubMed ID: 16496609
    [Abstract] [Full Text] [Related]

  • 4. 4G/5G promoter PAI-1 gene polymorphism is associated with plasmatic PAI-1 activity in Italians: a model of gene-environment interaction.
    Burzotta F, Di Castelnuovo A, Amore C, D'Orazio A, Di Bitondo R, Donati MB, Iacoviello L.
    Thromb Haemost; 1998 Feb; 79(2):354-8. PubMed ID: 9493590
    [Abstract] [Full Text] [Related]

  • 5. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
    Matsubara Y, Murata M, Isshiki I, Watanabe R, Zama T, Watanabe G, Watanabe K, Ikeda Y.
    Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
    [Abstract] [Full Text] [Related]

  • 6. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G, Berdeli A, Gürkan A, Han Saygan B, Köse T, Atilla G.
    J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
    [Abstract] [Full Text] [Related]

  • 7. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR.
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [Abstract] [Full Text] [Related]

  • 8. The study of gene-environment interactions that influence thrombosis and fibrinolysis. Genetic variation at the loci for factor VII and plasminogen activator inhibitor-1.
    Humphries SE, Lane A, Dawson S, Green FR.
    Arch Pathol Lab Med; 1992 Dec; 116(12):1322-9. PubMed ID: 1456879
    [Abstract] [Full Text] [Related]

  • 9. Genetic architecture of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
    Asselbergs FW, Pattin K, Snieder H, Hillege HL, van Gilst WH, Moore JH.
    Semin Thromb Hemost; 2008 Sep; 34(6):562-8. PubMed ID: 19085655
    [Abstract] [Full Text] [Related]

  • 10. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A, Emingil G, Saygan BH, Cinarcik S, Atilla G, Köse T, Berdeli A.
    J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
    [Abstract] [Full Text] [Related]

  • 11. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
    Pérez-Martínez P, Adarraga-Cansino MD, Fernández de la Puebla RA, Blanco-Molina A, Delgado-Lista J, Marín C, Ordovás JM, López-Miranda J, Pérez-Jiménez F.
    Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
    [Abstract] [Full Text] [Related]

  • 12. [The influences of genetic and environmental factors on plasma plasminogen activator inhibitor-1 levels in patients with essential hypertension].
    Song Y, Xu W, Chen Y, Che L, Wang Q, Zhou X, Wu J.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Dec; 16(6):374-6. PubMed ID: 10581347
    [Abstract] [Full Text] [Related]

  • 13. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.
    Meigs JB, Dupuis J, Liu C, O'Donnell CJ, Fox CS, Kathiresan S, Gabriel SB, Larson MG, Yang Q, Herbert AG, Wilson PW, Feng D, Tofler GH, Cupples LA.
    Obesity (Silver Spring); 2006 May; 14(5):753-8. PubMed ID: 16855181
    [Abstract] [Full Text] [Related]

  • 14. The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels.
    Asselbergs FW, Williams SM, Hebert PR, Coffey CS, Hillege HL, Navis G, Vaughan DE, van Gilst WH, Moore JH.
    Thromb Haemost; 2006 Oct; 96(4):471-7. PubMed ID: 17003924
    [Abstract] [Full Text] [Related]

  • 15. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
    Eroglu A, Ulu A, Cam R, Akar N.
    J BUON; 2006 Oct; 11(4):481-4. PubMed ID: 17309181
    [Abstract] [Full Text] [Related]

  • 16. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L, Jin H, Song K, Zhang C, Shen J, Huang Y.
    Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
    [Abstract] [Full Text] [Related]

  • 17. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.
    Prostate; 2007 Feb 01; 67(2):172-7. PubMed ID: 17044080
    [Abstract] [Full Text] [Related]

  • 18. Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer.
    Smolarz B, Blasiak J, Kulig A, Romanowicz-Makowska H, Dziki A, Ulanska J, Pander B, Szewczyk T.
    J Exp Clin Cancer Res; 2001 Jun 01; 20(2):247-52. PubMed ID: 11484982
    [Abstract] [Full Text] [Related]

  • 19. Genetic polymorphisms at FCER1B and PAI-1 and asthma susceptibility.
    Hizawa N, Maeda Y, Konno S, Fukui Y, Takahashi D, Nishimura M.
    Clin Exp Allergy; 2006 Jul 01; 36(7):872-6. PubMed ID: 16839401
    [Abstract] [Full Text] [Related]

  • 20. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
    Castelló R, España F, Vázquez C, Fuster C, Almenar SM, Aznar J, Estellés A.
    Thromb Res; 2006 Jul 01; 117(5):487-92. PubMed ID: 15907980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.